Carl Zeiss Meditec AG (AFXG)

Xetra
Currency in EUR
61.350
-0.700(-1.13%)
Delayed Data·
AFXG Scorecard
Full Analysis
Management has been aggressively buying back shares
AFXG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
61.35062.200
52 wk Range
44.28095.800
Key Statistics
Edit
Bid/Ask
61.30 / 61.40
Prev. Close
62.05
Open
61.75
Day's Range
61.35-62.2
52 wk Range
44.28-95.8
Volume
13.86K
Average Volume (3m)
261.5K
1-Year Change
-34.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFXG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
61.969
Upside
+1.01%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Carl Zeiss Meditec AG Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Employees
5713
Market
Germany

Compare AFXG to Peers and Sector

Metrics to compare
AFXG
Peers
Sector
Relationship
P/E Ratio
34.8x19.8x−0.5x
PEG Ratio
−0.880.380.00
Price/Book
2.6x2.0x2.6x
Price / LTM Sales
2.5x1.4x3.0x
Upside (Analyst Target)
−3.3%49.5%54.1%
Fair Value Upside
Unlock21.2%8.7%Unlock

Analyst Ratings

5 Buy
9 Hold
2 Sell
Ratings:
16 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 61.969
(+1.01% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.77%
Dividend Yield
0.97%
Industry Median 0.69%
Annualised payout
0.60
Paid annually
5-Years Growth
-1.59%
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.52 / 0.4117
Revenue / Forecast
560.02M / 525.45M
EPS Revisions
Last 90 days

People Also Watch

8.398
TKAG
+1.28%
106.23
CRUS
-0.62%
25.560
CBKG
+0.67%
32.150
RWEG
+0.22%
282.950
DB1Gn
-0.47%

FAQ

What Stock Exchange Does Carl Zeiss AG Trade On?

Carl Zeiss AG is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Carl Zeiss AG?

The stock symbol for Carl Zeiss AG is "AFXG."

What Is the Carl Zeiss AG Market Cap?

As of today, Carl Zeiss AG market cap is 5.37B.

What Is Carl Zeiss AG's Earnings Per Share (TTM)?

The Carl Zeiss AG EPS (TTM) is 1.77.

When Is the Next Carl Zeiss AG Earnings Date?

Carl Zeiss AG will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is AFXG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.